Found 190 matching trials
Alteration in Timing of Plerixafor Administration PHASE2 Typically, the collection of blood cells for autologous stem cell transplan...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion PHASE1 The study objectives are to evaluate the safety of a single intravenous (IV...
Show More Location
Sheba Medical Center - Tel Ashomer
Learn More & Join Trial
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients PHASE2 This study evaluates the safety and efficacy of plerixafor given in additio...
Show More Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder PHASE1 To evaluate the safety and feasibility of collecting hematopoietic stem cel...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant PHASE2 Plerixafor, administered at a dose of 240 ug/kg, potentiates the effect of ...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies N/A This is a retrospective observational cohort database analysis. The study w...
Show More Learn More & Join Trial
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma PHASE2 The current standard of care for the frontline treatment of peripheral T-ce...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma PHASE1 The purpose of this research study is to determine if plerixafor can make C...
Show More Location
UCSD Moores Cancer Center
Learn More & Join Trial
AMD 3100 for Treatment of Myelokathexis PHASE1 This is an initial study to determine if CXCR4 inhibitor AMD 3100 or plerix...
Show More Location
University of Washington Medical Center
Learn More & Join Trial
Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective N/A This study aims to observe the effects of the availability of plerixafor on...
Show More Location
Multiple Locations
Learn More & Join Trial